January 21, 2022
Oncopeptides rescinds voluntary withdrawal of Pepaxto in the US – no intent to market in the US at this time
Media
January 19, 2022
Nordic Nanovector ASA – Private placement of new shares successfully placed
January 18, 2022
Xeris Biopharma Reaffirms 2021 Guidance and Provides Business Update
January 17, 2022
Targovax granted Patents for ONCOS-102 in combination with chemotherapy in China and Japan
January 13, 2022
BONESUPPORT signs distribution agreement with OrthoPediatrics
January 13, 2022
Oncopeptides phase 3 OCEAN study published in the Lancet Haematology
January 12, 2022
Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway
January 11, 2022
Fusion Pharmaceuticals Announces Research Collaboration With 48Hour Discovery To Develop Peptide-Based Radiopharmaceuticals
January 11, 2022
Fusion Pharmaceuticals Announces Research Collaboration With Pepscan To Develop Peptide-Based Radiopharmaceuticals
January 10, 2022
Fusion Pharmaceuticals Announces Nomination Of First Targeted Alpha Therapy Candidate In Collaboration With AstraZeneca To Advance Into IND-Enabling Studies For Phase 1 Development
